Clinical Trial Update: Prevention of Nephrotoxin-Induced Acute Kidney Injury Using Cilastatin [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing whether cilastatin can prevent nephrotoxin-induced acute kidney injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Cilastatin (cilastatin)

Snippet

Sponsor: Matthew James | Conditions: Acute Kidney Injury | Phase 2 | Status: RECRUITING